Panbela Therapeutics P/E
What is the P/E of Panbela Therapeutics?
The P/E of Panbela Therapeutics Inc. is 0.00
What is the definition of P/E?
Price to earnings ratio is the ratio of a company’s stock price to the company’s earnings per share calculated over trailing twelve months.
= previous day’s close / ttm EPS
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E of companies in the Health Care sector on NASDAQ compared to Panbela Therapeutics
What does Panbela Therapeutics do?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Companies with p/e similar to Panbela Therapeutics
- Rurelec PLC has P/E of 0.00
- Tomizone has P/E of 0.00
- Nanogate AG has P/E of 0.00
- SEL Manufacturing has P/E of 0.00
- China Zhong Qi Hldgs has P/E of 0.00
- MedSmart has P/E of 0.00
- Panbela Therapeutics has P/E of 0.00
- Epic has P/E of 0.00
- 2574 has P/E of 0.00
- GERRY WEBER International AG has P/E of 0.00
- Houston Nat Res has P/E of 0.00
- CTPartners Executive Search has P/E of 0.00
- Crown ElectroKinetics has P/E of 0.00